We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIDH
RNS Number : 5597C
Immunodiagnostic Systems Hldgs PLC
28 June 2016
Immunodiagnostic Systems Holdings plc
Director Dealing
28 June 2016
Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, was advised on 28 June, that on 27 June, Peter Williamson, Non-Executive Director, acquired 30,000 ordinary shares of 2p each ("Ordinary Shares") in the Company at 140p per Ordinary Share.
Following these purchases, Mr Williamson is interested in 30,000 Ordinary Shares, 0.10% of the issued share capital of the Company.
For further information:
Hot Features
Premium
Immunodiagnostic Systems Tel : +44 (0)191
Holdings plc 519 0660
Patricio Lacalle, Chief
Executive Officer
Paul Martin, Group Finance
Director
Peel Hunt LLP Tel : +44 (0)207
418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBRGDLXBDBGLI
(END) Dow Jones Newswires
June 28, 2016 13:14 ET (17:14 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
